InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: SitTight post# 336083

Wednesday, 12/09/2020 9:09:18 PM

Wednesday, December 09, 2020 9:09:18 PM

Post# of 403025
It certainly sounds like Seqens has made a fairly significant investment in developing a more efficient and cost effective process for making Brilacidin. Makes you wonder why? There is currently no significant market for Brilacidin so what motivated Seqens? Could it be that there is more going on behind the scenes than we know?

SitTight said,

Just FYI: interesting new case study regarding the production of Brilacidin.

The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
https://www.pharmasalmanac.com/articles/the-importance-of-a-global-leader-in-small-molecule-manufacturing-during-the-covid-19-pandemic

Of course, IPIX's Brilacidin supplier is Evonik and not Seqens. But they seem eager and have an interesting approach to produce Brilacidin more efficiently.


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News